Preclinical Development of JNK3 Inhibitors to Treat Parkinson's Disease

$1,503,665U01FY2008NSNIH

Scripps Research Institute, The, La Jolla CA

Investigators

Philip Lograssocontact

Linked publications & trials

Paper 25825522 Paper 24332487 Paper 23751758 Paper 23258542 Paper 23184940 Paper 23142346 Paper 22351776 Paper 22284361 Paper 21666839 Paper 21666838 Paper 21563797 Paper 21454558 Paper 21316221 Paper 21185177 Paper 19947601 Paper 19433357 Paper 19261605

View original record on NIH RePORTER →